MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Advanced Melanoma
Related studies linked through entity extraction aliases.
Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy
- Status
- RECRUITING
- Phase
- PHASE1
ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
- Status
- RECRUITING
- Phase
- PHASE4
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- Status
- RECRUITING
- Phase
- PHASE4
A Phase II Trial of LM103 in Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Outcomes of Nivolumab in Combination With Relatlimab in Patients With Advanced Melanoma in the Flatiron Database
- Status
- COMPLETED
- Phase
- N/A
Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
HS-IT101 Injection in the Treatment of Advanced Melanoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
An Expanded Access Program for VO (RP1) in Combination With Nivolumab in Patients With Advanced Melanoma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
- Status
- RECRUITING
- Phase
- NA
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE2